MARCHESONI, Diego
 Distribuzione geografica
Continente #
NA - Nord America 20.931
EU - Europa 8.511
AS - Asia 8.445
SA - Sud America 1.473
AF - Africa 164
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 9
AN - Antartide 1
Totale 39.555
Nazione #
US - Stati Uniti d'America 20.628
SG - Singapore 4.216
UA - Ucraina 2.376
CN - Cina 1.894
DE - Germania 1.669
IT - Italia 1.367
BR - Brasile 1.255
HK - Hong Kong 943
FI - Finlandia 904
RU - Federazione Russa 604
VN - Vietnam 393
IE - Irlanda 369
SE - Svezia 366
GB - Regno Unito 289
IN - India 223
TR - Turchia 221
FR - Francia 216
CA - Canada 213
KR - Corea 181
AR - Argentina 91
PL - Polonia 76
CZ - Repubblica Ceca 60
IR - Iran 59
BD - Bangladesh 58
MX - Messico 56
ZA - Sudafrica 53
JP - Giappone 40
BE - Belgio 39
EC - Ecuador 37
ID - Indonesia 33
IQ - Iraq 28
NL - Olanda 27
AT - Austria 24
MA - Marocco 24
VE - Venezuela 24
TG - Togo 23
CO - Colombia 21
EU - Europa 21
ES - Italia 20
EG - Egitto 19
PK - Pakistan 18
UZ - Uzbekistan 16
CH - Svizzera 15
AZ - Azerbaigian 12
PY - Paraguay 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
BG - Bulgaria 11
RS - Serbia 10
KE - Kenya 9
LT - Lituania 9
PE - Perù 9
RO - Romania 9
TN - Tunisia 9
UY - Uruguay 9
CL - Cile 8
JO - Giordania 8
AU - Australia 7
DZ - Algeria 7
KG - Kirghizistan 7
PT - Portogallo 7
BO - Bolivia 6
GR - Grecia 6
IL - Israele 6
JM - Giamaica 6
MY - Malesia 6
NP - Nepal 6
OM - Oman 6
PS - Palestinian Territory 6
TW - Taiwan 6
HR - Croazia 5
KZ - Kazakistan 5
PA - Panama 5
AL - Albania 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
EE - Estonia 4
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
PH - Filippine 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
LI - Liechtenstein 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
Totale 39.523
Città #
Woodbridge 2.302
Ann Arbor 2.056
Chandler 1.854
Singapore 1.690
Jacksonville 1.671
Houston 1.393
Ashburn 1.181
Fairfield 1.163
Dearborn 978
Beijing 970
Hong Kong 939
Wilmington 643
Boardman 489
Munich 450
Princeton 394
Seattle 369
Dublin 368
Cambridge 319
Los Angeles 290
New York 251
Hefei 232
Helsinki 208
Buffalo 191
Dallas 191
Izmir 189
Seoul 171
Udine 170
Sacile 157
Des Moines 140
Ho Chi Minh City 136
San Diego 131
São Paulo 114
Ottawa 113
Grafing 99
Ogden 98
Norwalk 87
Redondo Beach 87
Mumbai 75
Hanoi 72
Nanjing 68
Turku 68
Monmouth Junction 63
Kunming 60
Brno 53
Milan 51
Leawood 50
Warsaw 50
San Mateo 43
The Dalles 42
Rio de Janeiro 41
Trieste 41
Jinan 40
Düsseldorf 39
Tokyo 39
Frankfurt am Main 37
Toronto 37
Ardabil 35
Brussels 35
Santa Clara 34
Simi Valley 34
Guangzhou 33
Montreal 32
Atlanta 30
Augusta 30
Stockholm 30
Belo Horizonte 29
London 29
Brooklyn 28
Washington 28
Résia 27
Denver 25
Johannesburg 25
Lomé 23
Orem 22
Redwood City 22
Rome 22
Chennai 21
Nanchang 21
Chicago 20
Council Bluffs 20
Mcallen 20
Nuremberg 20
Phoenix 20
Porto Alegre 20
Shenyang 20
Boston 19
Brasília 19
Portsmouth 19
Biên Hòa 18
Fuzhou 18
Radomsko 18
Haiphong 17
Jyväskylä 17
San Francisco 17
Campinas 16
Guayaquil 16
Palermo 16
Poplar 16
Hebei 15
Mexico City 15
Totale 24.264
Nome #
Comparison between bidimensional sonography and three dimensional power Doppler angiography (VOCALTM) for assessment of fetal renal blood flow in normal gestation 274
Comparision between Bidimensional Sonography and 3-dimensional Power Doppler Angiography (VOCAL) for Assessment of Fetal Renal Blood Flow in Normal Gestation 263
Comparision between Bidimensional Sonography and 3-Dimensional Power Doppler Angiography (Virtual Organ Computer-Aided Analysis) for Assessment of fetal renal blood flow in Normal Gestation 260
Gynaecological cancer management at the end of 20th century 244
INDUZIONE DELLA MATURAZIONE POLMONARE FETALE NELLA PROFILASSI DELLA MALATTIA DA MEMBRANE IALINE E SEPSI NEONATALE 219
Retinol binding protein as early marker of fetal growth restriction in first trimester maternal serum. 194
Sindrome uremico emolitica nel post partum, paziente affetta da sdr. HELLP. Case report. 191
A retrospective cohort study of the association of parity with urinary incontinence - Does the multiparity select an urinary incontinence resistant cohort? 185
Biochimica dello scatchard plot: vantaggi della competizione 182
Acute promyelocytic leukemia during pregnancy 182
Assessment of endometrial volume and vascularization using transvaginal 3D power Doppler angiography in women with postmenopausal bleeding. 179
CPR2 as a new Doppler parameter for assessment of wellbeing in fetal growth restricted fetuses 177
Second trimester maternal plasma and amniotic fluid adipokines in women who will develop gestational diabetes mellitus 176
Survivin, MMP-2, MT1-MMP, and TIMP-2: their impact on survival, implantation, and proliferation of endometriotic tissues 173
Bone ultrasonometry measurements during pregnancy 169
Assessment of fetale brain vascularization in fetal growth restriction comparing three-dimensional power angiography to bi-dimensional velocimetry 169
Body mass index, life style characteristics and post-menopausal symptoms 168
A proposal for a new scoring system to evaluate pelvic masses: Pelvic Masses Score (PMS) 168
Drugs and pregnancy: 5 year experience at the Teratologic Service of the Azienda Ospedaliero- Universitaria of Udine. 165
A new proposal of sonobiopsy of fetal brain using 3D power Doppler angiography (VOCAL) in normal and growth restricted fetuses 165
Building a Prediction Model for Vacuum-Assisted Operative Vaginal Delivery Risk 165
Ischemia modified Albumin in Pregnancy 163
Ischemia modified albumin in pregnancy 163
Puerperal ovarian vein thrombosis: two case reports 162
Valutazione dell'efficacia predittiva del modello di Gail nel calcolo del rischio di carcinoma della mammella 161
Diagnostic value of endometrial volume and vascular indices by 3D ultrasonography power Doppler angiography (3D-PDA) in patients with postmenopausal bleeding 160
Assessment of Fetal Brain Vascularization using Three-Dimensional Power Doppler Ultrasound Angiography in Pregnancies Affected by Fetal Growth Restriction 160
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 160
Three dimensional cerebroplacental ratio (CPR 3DPDA): a proposal of a new prameter for the antenatal surveillance in IUGR fetuses 157
Amniotic Band syndrome 155
FREQUENCY OF FACTOR V, PROTHROMBIN AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE VARIANTS IN PREECLAMPSIA 155
Fetal gender ratio in recurrent miscarriages 154
Incomplete pentalogy of Cantrell during first trimester of pregnancy: case report 152
Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. 147
Identification of risk factors and the use of quantitative ultrasounds (QUS) in order to select high risk of fracture women over 40 years old. Is osteoporosis screeening possible) 147
High placental index and poor pregnancy outcomes: a retrospective study of 18,386 pregnancies. 147
Combinated management of heterotopic Cesarean scar pregnancy 146
Near-miss and maternal mortality in a tertiary care facility in Italy 145
Chorangioma and Fetal Anemia: A Case Report 144
Parto-analgesia and post-partum blood loss 143
Sonobiopsia fetale cerebrale mediante angiografia tridimensionale power Doppler in feti normali e IUGR: una nuova proposta 142
Ischemia modified albumin in pregnancy 142
RISK FACTORS FOR TYPE 2 DIABETES IN WOMEN ATTENDING MENOPAUSE CLINICS IN ITALY: A CROSS-SECTIONAL STUDY 142
Lo screening della traslucenza nucale fetale: i risultati e la corretta comunicazione del test 140
A screening program for endometrial cancer in an asymptomatic postmenopausal population in our City: Preliminary data 140
Ultrasonographic assessment of cervix size and its correlation with female characteristics, pregnancy, BMI, and other anthropometric features 140
Oxidized Transthyretin in amniotic fluid as an early marker of preeclampsia 138
Valutazione prospettica di un test di screening combinato per la sindrome di Down presso il Centro di diagnosi prenatale della Clinica Ostetrica di Udine 138
A Metabolomic Approach to Selective Intrauterine Growth Restriction (sIUGR) in Monochorionic Pregnancies 137
Gynaecological aspects of primary Sjogren's syndrome 137
Modificazioni cardiovascolari materne in gravidanza 136
OBESITY REDUCES THE EXPRESSION OF GLUT4 IN THE ENDOMETRIUM OF NORMOINSULINEMIC WOMEN AFFECTED BY THE POLYCYSTIC OVARY SYNDROME 136
Ischemia - modified albumin in pregnancy 135
Therapy side-effects and predictive factors for preterm delivery in patients undergoing tocolysis with atosiban or ritodrine for threatened preterm labour. 135
Identification of patients with a high risk of osteoporosis. Analysis of risk factors, ultrasonography and DEXA, in a female population in the North East of Italy 135
Intrahepatic cholestatis of pregnancy; a in vivo model of the hepatic clearance of adiponectin 134
Feto-maternal outcome, epidural analgesia, and fetal occiput-posterior position 133
Cerebro Placental Ratio 2: a new Doppler parameter to assess the well being of the fetus 133
The diagnostic value of endometrial volume and vascularity measurement by transvaginal three–dimensional ultrasonography and Power Doppler angiography in patients with postmenopausal bleeding 133
Aplasia cutis congenita and vanishing twin syndrome 133
24-Hour ambulatory blood pressure monitoring in smoker and non smoker post-menopuasal women treated with ERT 133
Measurement of fetal urine production using trhee dimensional ultrasonography rotational technique (VOCALTM) in normal pregnancy 132
Ductus Venosus S-wave/isovolumetric A-wave (SIA) Index and A-Wave reversed flow in normal gestation 132
The Pelvic Masses Score (PMS): a proposed new scoring system to evaluate pelvic masses 132
Use of recombinant activated factor VII in severe post-partum haemorrhage: data from the Italian Registry: a multicentric observational retrospective study 132
Ischemia-modified albumin in pregnancy. 132
COMBINED INTRAUTERINE AND CERVICAL PREGNANCY DIAGNOSED IN THE 13TH GESTATIONAL WEEK: WHICH TYPE OF MANAGEMENT IS MORE FEASIBLE AND SUCCESSFUL? 132
Breast-feeding and benign breast disease 132
Climaterium ad an oncologic risk factor 131
Placenta percreta with bladder invasion. 131
Twin ectopic pregnancy in a previous cesarean scar section and subsequent fertility 131
Maternal cardiac haemodinamic changes during physiological pregnancy and psot-partum period 130
Assessment of Fetal Brain Vascularization using Three-Dimensional Power Doppler Ultrasound Angiography in Pregnancies affected by Fetal Growth Restriction 130
Metabolismo placentare e PAPP-A: studio prospettico sul ruolo del PAPP-A tra la 11° e la 13a settimana piu’ sei giorni di gestazione per valutare la funzionalità placentare 130
Localized ovarian cancer: surgery plus chemotherapy 129
Prepregnancy body mass index and adverse pregnancy outcomes 129
Genetic thrombophilias and uterine artery Doppler velocimetry and preeclampsia 128
L'aptoglobina: marker precoce di emolisi nella sindrome HELLP 127
Anthropometric factors and reproductive history of a population of young women affected by benign breast disease 127
Comparision of Pelvic Masses Score (PMS) and Risk of Malignancy Index (RMI3) in the evaluation of Pelvic Masses 127
Analisi retrospettiva su un anno di tagli cesarei: indicazioni e fattori di rischio per taglio cesareo in travaglio di parto [Retrospective analysis of one year of cesarean sections: indications and risk factors associated with intrapartum cesarean section] 127
Validation of pelvic masses score (PMS) in the preoperative evaluation of adnexal masses 126
Second trimester amniotic fluid retinol in patients developing preeclampsia. 126
Assessment of placental vascularization using three dimensional power Doppler Ultrasound in normal fetuses and fetuses affected by fetal growth restriction (IUGR) 126
Prediction of large-for-gestation neonates with first-trimester maternal serum PAPP-A 126
Use of intramyometrial injection of prostaglandin F 2 alpha in the management of intractable hemorrhage due to uterine atony 125
Evaluation of fetal cerebral blood flow perfusion using power Doppler ultrasound angiography (3D_PDA) in normal and growth-restricted fetuses (IUGR) 125
Menstrual abnormalities and predisposition to pregnancy-related hypertensive disorders: a retrospective study 125
Puerperal ovarian vein thrombosis: two case reports. PMID: 22890415 124
The diagnostic value of endoemetrial volume and vascularity measurements by transvaginal 3-dimensional ultrasonography and Power Doppler Angiography in patients with postmenopausal bleeding 124
Pathological monolateral Doppler velocimetry of the uterin artery and materno fetal outcome 123
’Comparison of 24mg and 12mg single-course Betamethasone prophilaxis: a retrospective study 123
Dal calcolo statistico alla sala parto: analisi del rischio di sproporzione cefalo pelvica e di ricorrere al tagli ocesareo 122
A woman presenting rheumatic cardiopathy in pregnancy: a case report 122
[Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature] 121
Prediction of large-for-gestation neonates with first trimester maternal serum PAPP-A 121
Amniotic fluid studies in gestosis 120
Induction of fetal lung maturation in the prevention of hyaline membrane disease: the connection with neonatal sepsis 120
Twin anemia-polycytemia sequence (TAPS): a case report 120
Measurement of fetal urine production by three – dimensional ultrasonography in normal pregnancy 118
Totale 14.799
Categoria #
all - tutte 145.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.481 0 0 0 0 0 510 55 440 645 80 648 103
2021/20223.113 49 490 108 312 47 51 171 207 37 437 638 566
2022/20233.951 450 267 161 447 400 1.082 9 295 555 26 128 131
2023/20241.126 181 86 43 14 173 223 23 73 132 46 25 107
2024/20257.463 179 476 274 240 276 339 514 567 921 610 1.274 1.793
2025/20266.096 1.033 1.132 817 1.048 1.892 174 0 0 0 0 0 0
Totale 39.744